Greatmark Investment Partners, Inc. Mannkind Corp Transaction History

Greatmark Investment Partners, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$3.14 - $6.14 $54,950 - $107,450	-17,500 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$1.56 - $2.08 $7,800 - $10,400	5,000 Added 40.0%	17,500 $33,000
Q1 2019 May 07, 2019	BUY	$1.14 - $2.25 $14,249 - $28,125	12,500 New	12,500 $25,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.53B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.